ResearchMoz

Global and China Automotive Industrial Robotics Industry Report,2013 - 2014

Research In China
Published Date » 2014-01-21
No. Of Pages » 90
 The global industrial robotics market valued around USD11.156 billion in 2012, but the value slumped by 17% to USD9.249 billion in 2013 because of the yen depreciation and a significant decline in the average price of industrial robotics. 
   
 In 2013, the global shipment of industrial robotics slightly rose by 2%. Japan’s industrial robotics shipment fell by 7.3% to 106,225 sets, and the average selling price dropped from JPY4.72 million in 2012 to JPY4.52 million in 2013. Thanks to the strong recovery in Europe, the U.S. and Japan, their demand for industrial robotics will not be less than China in 2014. The global market value is expected to increase by 3.5% to USD9.569 billion in the same year. 
   
 Although Japan’s industrial robotics shipment declines, Japanese...
Table of Content

1 Introduction to Industrial Robotics
1.1 History
1.2 Cost Structure

2 Global Industrial Robotics Market
2.1 Scale
2.2 Regional Analysis
2.3 Downstream
2.4 Service Robotics
2.5 Industrial Distribution in China
2.6 China’s Import and Export
2.7 Market Share of Major Enterprises in China
2.8 USA Market

3 Industrial Robotics Industry
3.1 Supply Chain 
3.2 Global Industrial Ranking 
3.3 Japan's Industrial Research 
3.4 Japan's Industrial Structure 
3.5 Automotive Industrial Robotics Industry 
3.6 Overview of Chinese Automobile Market 
3.7 Status Quo of Chinese Automobile Market
3.7.1 Status Quo of Passenger Car Market 
3.7.2 Commercial Vehicle Market 
3.8 China Automobile Industry

4 Major Industrial Robotics Enterprises
4.1 ABB
4.2 FANUC
4.3 Kawasaki Heavy Industries
4.4 COMAU
4.5 Yaskawa Electric 
4.6 KUKA
4.6.1 REIS
4.7 OTC (DAIHEN)
4.8 IGM
4.9 NACHI
4.10 ADEPT
4.11 NABTESCO
4.12 HARMONIC DRIVE SYSTEM
4.13 Shenyang SIASUN
4.14 DURR

List of Tables


List of Figures

Upcoming Reports:

Nanoparticles in Biotechnology, Drug Development and Drug Delivery Market - Global Forecast, Market Share, Size, Growth and Industry Analysis, 2012 - 2018
By - Transparency Market Research
Nanoscience or nanotechnology is the study of management of materials at molecular or atomic scale on different applications. The market for nanoparticles in drug technology holds prime share in the global pharmaceuticals market. Applications of nanotechnology can be classified into nanomedicine, chemicals and cosmetics, materials, food technology, energy, military, electronics, agriculture and others. Use of nanoparticles in pharmaceutical technology is mainly driven by growth in demand for personalized medicine. This market is classified according to applications such as...
Poland: processed poultry meat market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the processed poultry meat market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the processed poultry meat market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an...
Gems And Jewellery Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
The Gems and Jewellery industry is growing because of the rising income levels of consumers as well as the increasing usage of ornaments in the ceremonies in Asian countries. In Asian countries, people are moving away from the traditional unorganized jewellery shops towards the organized branded products to protect themselves from counterfeit products. The increasing advertisement spends of the gems and jewellery companies are generating awareness about the benefits of shopping from organized retail and it has also led to increasing ornament gifting habit in Asian countries. The easy...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...